[DGTR tracker](https://indusdesk.com/dgtr/tracker/)

# DGTR opens anti-dumping investigation into clavulanic acid from China and the EU

https://indusdesk.com/dgtr/tracker/opens-anti-dumping-investigation-into-clavulanic-acid-276914/

DGTR published its initiation in SETU Case ID: AD/OI/054/2026 on September 30, 2026. DGTR initiates an anti-dumping investigation, dated September 30, 2026, into clavulanic acid and its amine salt from China and the European Union. It covers Clavulanic Acid (also known as Potassium Clavulanate) and its Amine Salt from China and European Union.

SETU Case ID: AD/OI/054/2026 · Initiation · September 30, 2026

IndusDesk · September 30, 2026

The Directorate General of Trade Remedies has initiated an anti-dumping investigation, by notification dated September 30, 2026 (SETU Case ID AD/OI/054/2026), concerning imports of Clavulanic Acid (also known as Potassium Clavulanate) and its Amine Salt originating in or exported from China and the European Union.

The application was filed by Kinvan Private Limited, which began commercial production on March 30, 2024 at Nalagarh, Himachal Pradesh, and is treated as the sole domestic producer of the like article. The product is an Active Pharmaceutical Ingredient used with penicillin-class antibiotics; sterile grades, and Amine Salts meant for producing them, are excluded. It is classified under tariff items 2941 90 90 and 2931 99 90, and quantities are to be reported in kilograms.

The period of investigation is April 1, 2025 to March 31, 2026, and the injury period covers 2022-23 to the period of investigation. For initiation, normal value for both subject countries was constructed from the domestic industry's cost of production, and export price was taken from DG Systems data. The Authority finds a prima facie dumping margin above de minimis, and the information on record prima facie indicates injury in the form of material retardation to the establishment of the domestic industry.

Interested parties must register on the SETU Portal and file responses within 37 days from circulation of the non-confidential version of the application. Comments on the product scope and PCN methodology are due within 15 days of initiation, running concurrently. The Authority will determine the existence, degree and effect of the alleged dumping and recommend any duty adequate to remove the injury in the form of material retardation.

**Measure**: Anti-dumping

**Stage**: Initiation

**Case number**: SETU Case ID: AD/OI/054/2026

**File number**: F. No. 6/51/2026-DGTR

**Dated**: September 30, 2026

**Published in the Gazette**: September 30, 2026

**Put online**: October 7, 2026

**Gazette ID**: CG-DL-E-07102026-276914

**Product**: Clavulanic Acid (also known as Potassium Clavulanate) and its Amine Salt

**What it covers**: Clavulanic Acid, also known as Potassium Clavulanate, an Active Pharmaceutical Ingredient used as an adjuvant in penicillin-class antibiotic formulations, and its Intermediate Amine Salt (N-1 stage). Sterile Grade of Clavulanic Acid and Amine Salts meant for production of Sterile Grade of Clavulanic Acid are excluded. The customs classification is indicative only and not binding on the scope; the product is also imported under other HS codes.

**Customs codes**: 2941 90 90, 2931 99 90

**Countries**: China, European Union

**Applicant**: Kinvan Private Limited

**Period of investigation**: 1st April 2025 to 31st March 2026 (12 months)

**Injury period**: 2022-23, 2023-24, 2024-25 and the POI

**Findings**:

- The applicant commenced commercial production on 30th March 2024 at Nalagarh, Himachal Pradesh, and is considered the sole domestic producer of the like article, accounting for 100% of domestic production; Vardhman Chemtech Limited produces only the excluded sterile grade and was not considered a producer of the like article.

- For both China and the European Union, normal value was constructed for initiation on the cost of production of the domestic industry, adjusted for selling, general and administrative expenses and reasonable profit.

- Export price was determined from the CIF price reported in DG Systems data, adjusted to the ex-factory level.

- The comparison of normal value and export price prima facie indicates a dumping margin above the de minimis level and significant for the subject countries.

- The information on record prima facie indicates injury in the form of material retardation to the establishment of the domestic industry, with the applicant claiming sub-optimal capacity utilization, inability to achieve a reasonable market share, sales below cost, financial losses and negative return on capital employed.

**Recommendation**: The Authority initiates an anti-dumping investigation under Section 9A of the Act read with Rule 5 of the Rules to determine the existence, degree and effect of the alleged dumping and to recommend the anti-dumping duty adequate to remove the injury in the form of material retardation to the establishment of the domestic industry.

**Time limits**:

- Comments on the scope of the product under consideration and the proposed PCN methodology: within fifteen (15) days from the date of initiation, running concurrently with the time limit for submissions

- Confidential and non-confidential versions of questionnaire responses and submissions on the SETU Portal: within 37 days from the date on which the non-confidential version of the application is circulated by the Authority in SETU Portal or transmitted to the diplomatic representatives of the exporting countries

- Requests for extension of time, through the SETU Portal: at least 3 days before the original deadline

- Comments on confidentiality claims made by other parties: within 7 days from the date of circulation of the non-confidential version of the documents

[The notification](https://files.indusdesk.com/dgtr/cases/setu-ad-oi-54-2026/initiation-2026-09-30.pdf) (PDF, 686 KB)

Gazette of India, [CG-DL-E-07102026-276914](https://egazette.gov.in/WriteReadData/2026/276914.pdf), published September 30, 2026.

Checked against the official copy on October 20, 2026.

- [DGTR guide](https://indusdesk.com/dgtr/)

- [All DGTR notifications](https://indusdesk.com/dgtr/tracker/)
